New York — April 19, 2026 — CELFULL®, a global leader in clinical-driven biotechnology announced its participation in Vitafoods Europe 2026 (Booth [5A70D]), taking place May 5–7 in Barcelona. Following its high-impact debut at SupplySide West, the brand will showcase its 25-year evolution from laboratory innovation to a dual-track "Drugs + Supplements" R&D powerhouse.
Bridging the Gap: From Clinical R&D to Consumer Vitality
Unlike conventional raw material suppliers, CELFULL operates as a serious medical innovator. Founded by a team of PhDs from the world’s elite universities , the brand focuses on the nine key mechanisms of aging. This rigorous scientific foundation allows CELFULL to translate complex drug-stage research—including pipelines for cardiovascular and neurological health—into high-performance consumer interventions.
"Our mission is to replace 'basic wellness' with 'precision intervention'," says Dr. Juliane Hitzel, CEO of CELFULL and PhD in Biochemistry. "At Vitafoods, we are not just presenting a product; we are presenting a blueprint for the future of human healthspan."
The Turn A® Advantage: Solving the Stability Crisis
A central highlight of the exhibition will be CELFULL’s proprietary Turn A® (Celfavor™) delivery technology. While ordinary NADH supplements suffer from rapid degradation, CELFULL’s patented four-layer coating—comprising water-resistant, oxygen-barrier, anti-gastric acid, and enteric layers—ensures:
-
3-Year Shelf Stability: The only NADH formulation capable of remaining shelf-stable for up to 36 months.
-
Acid Resistance: Bypasses stomach acid to absorb directly in the intestine for maximum potency.
-
Superior Efficiency: Delivering up to 4 times the efficiency of traditional NAD+ boosters like NMN.
A Global Intellectual Property Fortress
CELFULL’s competitive moat is reinforced by a robust global patent portfolio. As of early 2026, the company has secured 43 authorized invention patents across the U.S., China, Japan, Canada, and Australia. These protections cover not only novel anti-aging substances but also the advanced formulation technologies that ensure safe, long-term consumer use.
Driving the Scientific Ecosystem
Beyond product innovation, CELFULL is a key collaborator in the world’s largest clinical studies, including female reproductive health (NCT05305677). At Vitafoods, the team will present its latest AI-aided multi-target research and real-world data, advocating for a transition from "single-ingredient" sales to "whole life cycle health management."
About CELFULL®
CELFULL® is a premier biotechnology brand specializing in serious anti-aging solutions. With over two decades of expertise, CELFULL integrates AI-driven network pharmacology with traditional aging biology to deliver personalized, scientifically sound supplements. From its roots at Cornell University’s Professor Wu Rui’s laboratory to its current global R&D institute, CELFULL remains dedicated to extending the human healthspan.
Business Inquiries:
Maggie R.
CELFULL BIO-TECH (USA) Inc.
maggie@celfull.com
www.celfull.com
